FDA Announces Public Advisory Committee Meeting on Cellular, Tissue, and Gene Therapies

Summary

The FDA is hosting a public meeting of the Cellular, Tissue, and Gene Therapies Advisory Committee to discuss a biologics license application for debamestrocel, a treatment for amyotrophic lateral sclerosis (ALS), and is seeking public comments on the matter.